These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15833353)

  • 1. Serum or plasma: what kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?
    Jung K
    J Neuroimmunol; 2005 May; 162(1-2):1-2. PubMed ID: 15833353
    [No Abstract]   [Full Text] [Related]  

  • 2. Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases.
    Jung K; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2006 Nov; 373(1-2):180-1; author reply 182. PubMed ID: 16616058
    [No Abstract]   [Full Text] [Related]  

  • 3. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
    Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
    Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum matrix metalloproteinases and tympanosclerosis.
    Aslan H; Başoğlu MS; Sentürk B; Ozbay C; Katilmiş H; Oztürkcan S
    J Laryngol Otol; 2011 Feb; 125(2):142-6. PubMed ID: 20955636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
    Ichiyama T; Siba P; Suarkia D; Takasu T; Miki K; Kira R; Kusuhara K; Hara T; Toyama J; Furukawa S
    J Neurol Sci; 2007 Jan; 252(1):45-8. PubMed ID: 17118404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitors of matrix metalloproteinase-1 levels are increased in serum of patients with allergic contact dermatitis.
    Reduta T; Laudańska H; Laudanski P
    Contact Dermatitis; 2007 Aug; 57(2):100-4. PubMed ID: 17627649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
    Sunagawa S; Ichiyama T; Honda R; Fukunaga S; Maeba S; Furukawa S
    Brain Dev; 2009 Sep; 31(8):588-93. PubMed ID: 18849127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis.
    Ichiyama T; Kajimoto M; Suenaga N; Maeba S; Matsubara T; Furukawa S
    J Neuroimmunol; 2006 Mar; 172(1-2):182-6. PubMed ID: 16321449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.
    Rauvala M; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2.
    Rossignol P; Jacob MP; Cambillau M; Mouradian D; Plouin PF; Chatellier G
    Thromb Res; 2007; 119(2):261-3. PubMed ID: 16530811
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
    Ichiyama T; Morishima T; Kajimoto M; Matsushige T; Matsubara T; Furukawa S
    Pediatr Infect Dis J; 2007 Jun; 26(6):542-4. PubMed ID: 17529876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.
    Aharinejad S; Krenn K; Zuckermann A; Schäfer R; Paulus P; Seebacher G; Wolner E; Grimm M
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):48-51. PubMed ID: 17482473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
    Honkavuori M; Talvensaari-Mattila A; Puistola U; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2008; 28(5A):2715-9. PubMed ID: 19035300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease.
    Inspector M; Aharon-Perez J; Glass-Marmor L; Miller A
    Eur Neurol; 2005; 53(3):155-7. PubMed ID: 15942243
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer.
    Rauvala M; Turpeenniemi-Hujanen T; Puistola U
    Anticancer Res; 2006; 26(6C):4779-84. PubMed ID: 17214341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.